ANAB

NASDAQStock

AnaptysBio, Inc.

$63.13-1.54 (-2.38%)

52-Week Range

$16.14
$64.67

Key Stats

Market Cap

1.7B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.41

Volume

396.5K

Avg Volume

513.5K

Performance

1M

+15.46%

3M

+40.01%

6M

+216.42%

YTD

+41.91%

1Y

+278.80%

3Y

+178.68%

5Y

+222.01%

Price Chart

ETF Exposure

ANAB is held by 68 ETFs

ETFFund NameWeight
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
SPGMState Street SPDR Portfolio MSCI Global Stock Market ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
AVSUAvantis Responsible U.S. Equity ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
PreviousPage 2 of 2

About ANAB ETF Exposure

AnaptysBio, Inc. (ANAB) is held by 68 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.7B, ANAB is a widely held institutional stock. The stock currently trades at $63.13. Investors can gain exposure to ANAB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ANAB, sorted by portfolio weight.